Quince Therapeutics, Inc. (QNCX)

NASDAQ: QNCX · IEX Real-Time Price · USD

0.738

+0.013 (1.72%)

At close: Jul 2, 2024, 4:00 PM

0.746

+0.008 (1.08%)

After-hours: Jul 2, 2024, 6:10 PM EDT

Quince Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2017
Net Income	-31.39	-51.66	-89.95	-76.85	-36.98	Upgrade
Depreciation & Amortization	0.32	0.2	0.34	0.33	0.19	Upgrade
Share-Based Compensation	5.22	16.62	29.85	14.47	2.06	Upgrade
Other Operating Activities	7.55	-9.2	-3.18	11.23	1.46	Upgrade
Operating Cash Flow	-18.29	-44.04	-62.93	-50.82	-33.28	Upgrade
Capital Expenditures	-0.07	-0.06	-0.18	-0.05	-0.06	Upgrade
Acquisitions	-2.12	10.59	0	0	0	Upgrade
Change in Investments	-3.57	7.47	59.13	-52.38	-17.69	Upgrade
Investing Cash Flow	-5.76	18	58.95	-52.43	-17.75	Upgrade
Share Issuance / Repurchase	0.15	0.76	6.81	118.91	77.93	Upgrade
Debt Issued / Paid	-0.01	-0.05	0	-0.03	-0.56	Upgrade
Financing Cash Flow	0.14	0.71	6.81	118.88	77.37	Upgrade
Exchange Rate Effect	0.08	0.18	0.06	0	0	Upgrade
Net Cash Flow	-23.83	-25.15	2.88	15.63	26.34	Upgrade
Free Cash Flow	-18.36	-44.1	-63.11	-50.87	-33.33	Upgrade
Free Cash Flow Per Share	-0.49	-1.32	-2.12	-1.74	-1.75	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).